Regression of a malignant chest wall lymphoma associated with systemic lupus erythematosus achieved by small amounts of steroid therapy: a case report
Miwako Saitou Tomoko Suzuki Katsunao Niitsuma
Department of Infectious Disease and Pulmonary Medicine, Aizu Medical Center, Fukushima Medical University
In Japan, most malignant lymphomas of the chest wall are associated with pyothorax, with poor prognosis being reported.
An 81-year-old man developed pleurisy 4 years ago and low-grade oral steroid therapy (30mg/day to 5mg/day) was started for suspected collagen disease. While suffering from the collagen disease, he fulfilled the criteria for systemic lupus erythematosus (SLE). His disease went into remission, so steroid therapy was stopped after administration for 3 years and 6 months. Six months after cessation of steroids, he was admitted to our hospital complaining of high fever, and a right chest wall tumor was detected. Echo-guided biopsy revealed diffuse large B-cell lymphoma of the chest wall. The patient and his family did not wish for aggressive treatment, so oral steroids at 5mg/day were restarted and the chest wall tumor disappeared within 1 month. This is a very rare case of regression of malignant SLE-associated lymphoma achieved by small amounts of steroid therapy.
Malignant chest wall lymphoma Pleurisy Systemic lupus erythematosus (SLE) Spontaneous regression Steroid
Received 27 Dec 2017 / Accepted 18 Apr 2018
AJRS, 7(4): 216-219, 2018